| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| TDP1 protein | 14 | 0 | 0 | 14 |
| Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
| AR protein | 15 | 0 | 0 | 15 |
| aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| estrogen nuclear receptor alpha | 14 | 0 | 0 | 14 |
| peroxisome proliferator activated receptor gamma | 11 | 0 | 0 | 11 |
| euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
| flap endonuclease 1 | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| geminin | 12 | 0 | 0 | 12 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
| Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 9 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 9 | 0 | 9 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Cellular tumor antigen p53 | 11 | 0 | 0 | 11 |
| Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 12 | 0 | 0 | 12 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| IDH1 | 4 | 0 | 0 | 4 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 3 | 3 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 7 | 0 | 0 | 7 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 2 | 7 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Glutamate receptor 2 | 7 | 0 | 0 | 7 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 1 | 3 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 2 | 4 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 4 | 2 | 7 |
| Adenosine receptor A2a | 0 | 1 | 1 | 3 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 3 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Chain A, retinol dehydratase | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 12 | 0 | 0 | 12 |
| GLI family zinc finger 3 | 12 | 0 | 0 | 12 |
| estrogen receptor 2 (ER beta) | 9 | 0 | 0 | 9 |
| progesterone receptor | 10 | 0 | 0 | 10 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| estrogen-related nuclear receptor alpha | 12 | 0 | 0 | 12 |
| pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 6 | 1 | 0 | 7 |
| Sex hormone-binding globulin | 0 | 0 | 5 | 5 |
| Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 4 | 0 | 4 |
| Androgen receptor | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit delta | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 1 | 0 | 7 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 4 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 1 | 0 | 7 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 3 | 3 |
| GABA theta subunit | 6 | 1 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit epsilon | 6 | 1 | 0 | 7 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| thioredoxin reductase | 6 | 0 | 0 | 6 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| alpha-galactosidase | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 4 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| Interferon beta | 6 | 0 | 0 | 6 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 3 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Cholesterol 24-hydroxylase | 0 | 1 | 1 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 10 | 0 | 0 | 10 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 2 | 0 | 3 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Steryl-sulfatase | 0 | 3 | 0 | 5 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| Cereblon isoform 4 | 0 | 4 | 0 | 4 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
| Choline O-acetyltransferase | 0 | 2 | 0 | 2 |
| Protein cereblon | 0 | 4 | 0 | 4 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Estrogen receptor | 0 | 4 | 1 | 6 |
| Glucocorticoid receptor | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Olfactory receptor 51E2 | 0 | 1 | 1 | 2 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| GALC protein | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| G | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| lamin isoform A-delta10 | 9 | 0 | 0 | 9 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Aromatase | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Estrogen receptor beta | 0 | 1 | 1 | 3 |
| Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| Smad3 | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| corticotropin-releasing hormone receptor 2 | 0 | 1 | 1 | 2 |
| EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
| polyprotein | 2 | 0 | 0 | 2 |
| corticotropin releasing factor-binding protein | 0 | 1 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2E1 | 0 | 0 | 1 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 3 |
| Plasma kallikrein | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 0 | 2 |
| Oleandomycin glycosyltransferase | 0 | 0 | 0 | 1 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| Parkin | 2 | 0 | 0 | 2 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| caspase-3 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Trypsin | 0 | 1 | 0 | 1 |
| Papain | 0 | 1 | 0 | 1 |
| Serine protease hepsin | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 1 | 0 | 1 |
| Cathepsin B | 0 | 2 | 0 | 2 |
| Pro-cathepsin H | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Calpain-1 catalytic subunit | 0 | 1 | 0 | 1 |
| Cathepsin K | 0 | 1 | 0 | 1 |
| Hepatocyte growth factor activator | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 6 | 0 | 1 | 0 | 1 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| Cysteine protease falcipain-3 | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Chain A, Antigen Cd11a (p180) | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| PINK1 | 1 | 0 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| caspase-3 | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Integrin beta-2 | 0 | 1 | 0 | 1 |
| Intercellular adhesion molecule 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Integrin alpha-L | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
| Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 2 | 3 |
| Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 1 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| C-X-C chemokine receptor type 5 isoform 1 | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
| apelin receptor | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Endoglycoceramidase II | 0 | 0 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 1 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 0 | 1 | 1 |
| Retinoic acid receptor beta | 0 | 0 | 1 | 1 |
| Retinoic acid receptor gamma | 0 | 0 | 1 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 1 | 0 | 1 |
| RNA-directed RNA polymerase | 0 | 1 | 1 | 2 |
| Albumin | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |